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that circular RNA100783 is involved in chronic
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Abstract
Background: Ageing brings about the gradual deterioration of the immune system, also known as immunosenescence.
The role of non-coding circular RNA in immunosenescence is under studied. Using circular RNA microarray
data, we assembled Comparison groups (C1, C2, C3 and C4) that allowed us to compare the circular RNA
expression profiles between CD28(+)CD8(+) T cells and CD28(-)CD8(+) T cells isolated from healthy elderly or
adult control subjects. Using a step-wise biomathematical strategy, the differentially-expressed circRNAs were
identified in C1 (CD28(+)CD8(+) vs CD28(-)CD8(+)T cells in the elderly) and C4 (CD28(-)CD8(+)T cells in the
elderly vs in the adult), and the commonly-expressed circRNA species from these profiles were optimized as
immunosenescence biomarkers.
Results: Four overlapping upregulated circular RNAs (100550, 100783, 101328 and 102592) expressed in
cross-comparison between C1 and C4 were validated using quantitative polymerase chain reaction. Of these,
only circular RNA100783 exhibited significant validation. None of the down-regulated circular RNAs were expressed in
the C1 and the C4 cross-comparisons. Therefore, we further predicted circular RNA100783-targeted miRNA-gene
interactions using online DAVID annotation. The analysis revealed that a circular RNA100783-targeted miRNA-mRNA
network may be involved in alternative splicing, the production of splice variants, and in the regulation of
phosphoprotein expression. Considering the hypothesis of splicing-related biogenesis of circRNAs, we propose
that circular RNA100783 may play a role in phosphoprotein-associated functions duringCD28-related CD8(+)
T cell ageing.
Conclusions: This study is the first to employ circular RNA profiling to investigate circular RNA-micro RNA interactions in
ageing human CD8(+)T cell populations and the accompanying loss of CD28 expression. The overlapping expression of
circular RNA100783 may represent a novel biomarker for the longitudinal tracking ofCD28-related CD8(+) T cell ageing
and global immunosenescence.
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Background
The ongoing loss of immune function during ageing, or
immunosenescence, is a major contributor to the increas-
ing morbidity and mortality in the elderly population. One
of the prominent alterations on immune cells during this
process is the gradual loss of the co-stimulatory molecule,
CD28, from the surface of CD8(+) T lymphocytes [1, 2].
Thus, an increase in the CD28(-)CD8(+) T subset is con-
sidered to be one hallmark of immunosenescence [3].
However, except for their replicative characteristics during
senescence [4, 5], very little is known regarding the exact
nature, origin and function of CD28(-)CD8(+)T cells [1].
Indeed, the mechanism by which CD28 is lost from
CD28(+)CD8(+)T cell surface is complicated. During an
individual’s lifespan, CD28(+)CD8(+)T cells are gradually
stimulated by encounters with numerous antigens result-
ing in CD28 exhaustion. Latent human cytomegalovirus
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(CMV) is responsible for the greatest clonal expansion of
CD28(-)CD8(+) T cells in the healthy elderly population
[6–9]. Latent CMV carriers are so prevalent that CMV
seropositivity has been proposed as one of the “Immune
Risk Profiles (IRPs)”, and individuals in the general elderly
population who exhibit high IRP have an increased risk of
all-cause mortality [10, 11]. Moreover, microarray ana-
lyses of elderly and adult control subjects revealed that
754 genes representing a wide range of biological pro-
cesses and cellular functions are significantly altered in
human CD8(+) T cells [12]. It has been observed that
CD28(-)CD8(+) T cells demonstrated similar patterns of
gene expression in elderly and adult subjects [13, 14], while
the profiles of gene expression in CD28(+)CD8(+) T cells
are profoundly altered in adult and the elderly populations
[14]. However, the disparities between adult and old, as
well as between CD28(-)CD8(+) and CD28(+)CD8(+)T
cells, remain unexplored.
More than 25,000 species of an enigmatic class of
circular RNAs have been identified in various human
cells [15]. At least two circular RNAs have been demon-
strated to function as molecular sponges to their target
miRNAs [16, 17]. It has been hypothesized that circular
RNAs are produced by non-random back-splice events
that forma covalently closed continuous loop [18], and
some generalized mechanism might strictly determine
whether splicing produces a circular non-coding RNA or
a linear mRNA [19]. The expression of circRNA was
found to be tissue- as well as developmentally-specific
[17, 20]. The levels of circular RNAs also increase in an
age-related manner in Drosophila [21]. Until the present
study, age-related circular RNA profiling in lymphocytes,
and the circRNA-dependent molecular regulation ofCD28
exhaustion from the surface of CD8(+)T cell, has remained
under studied.
The development of circRNA microarray (http://
www.kangchen.com.cn/english/) has facilitated the study
of the role of circular RNAs in regulating gene expression
through a circRNA-miRNA-mRNA network. To explore
the underlying molecular regulation of circRNAs in T cell
ageing, we first used circular RNA microarray detection to
acquire circRNA profiles in CD28-dependent CD8(+)T
cell subsets in elderly individuals(Q1 and Q2) and adult
controls (Q3 and Q4). Based on it, we compared cross
them to acquire four cross-differentiated circular RNA
profiles (C1,C2, C3 and C4). Then we performed step-
wise bioinformatics analysis to identify the overlapping
circular RNA molecules between C1 and C4 as potential
biomarkers of CD8+T cell immunosenescence.
Results and discussions
Clinical characteristics of the enrolled subjects
We enrolled in our study a total of 21 apparently healthy
elderly individuals and 8 healthy adult volunteers, who
had been initially identified as CMV latent carriers by
CMV-IgG detection. The general clinical characteristics
of the 29 participants are shown in Table 1.
General profiles of circRNA microarray
Overall, 2171 circRNAs were significantly up-regulated
among the four comparison groups (NC1(Q1vsQ2) = 478,
Nc2(Q3vsQ4) = 272,NC3(Q1vsQ3) = 671,NC4(Q2vsQ4) = 741). (For
the concise aim, we abbreviated circular RNA as “circRNA”
in the following manuscript). In these same groups, 1563
circRNAs were significantly down-regulated (NC1(Q1vsQ2) =
337,Nc2(Q3vsQ4) = 332,NC3(Q1vsQ3) = 438,NC4(Q2vsQ4) = 456).
We ranked the circRNAs according to fold-change (FC) in
expression levels of the 4 comparison profiles and listed
the Top10 candidates (“Top 10”) of each comparison in
Additional file 1: Table S1.
Identification of Top-5 miRNAs according to mirSVR
For each circRNA with fold changes in expression levels
greater than 2 in the four comparison groups, we ranked
their targeted miRNAs according to mirSVR scores and
identified the 5 highest ranking candidates (“Top 5”) fur-
ther analysis (for details see Additional file 2: Online
Supplemental Excel 1). We then utilized Cytoscape to
construct circRNA-miRNA networks of interaction
between those circRNA exhibiting a 2-fold or greater
change in expression (up-regulated and down-regulated
expression) and their Top 5 targeted miRNAs (desig-
nated as “Top-5 network”) (Additional file 3: Figure S1).
Since the number of targeted miRNAs that interplayed
with each circRNA in these two networks was almost
equal (NmiRNA = 5), the profiles of these two networks
appeared to be similar. There were more molecular
interactions in the down-regulated Top-5network (2338
nodes with 7723 edges) than in the up-regulated Top-5
network (1865 nodes with 5558 edges).
Identification of overlapping circRNAs between C1 and C4
Until now, the molecular interactions between most cir-
cRNAs and their target miRNAs have been addressed by
theoretical prediction based on the principle of base-
paring. Moreover, for any one circRNA, at least more
than ten miRNAs have been predicted as potential
targets. Therefore, it can be challenging to define
which circRNA molecules play more critical or pivotal
roles in a complex circRNA-miRNA network. Here,
we supposed that circRNAs that interact with more
miRNA targets play a more significant role in the general
circRNA-miRNA network, than do those circRNAs that
interact with fewer targets. Based on this hypothesis, we
designed a step-wise strategy to optimize potential candi-
date circRNAs.
Firstly, among the up-regulated and down-regulated
Top-5 networks, the Top-10 % miRNAs ranked by
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miRNA-dependent degree (D) were optimized for
next step. In the re-ranked Top-10 % up-regulated
network, 75 up-regulated miRNAs (Additional file 1:
Table S3-1) with degree values ranging from 22 to 60
were selected. The highest degree of miRNA was hsa-
miR-136-5p (D = 60), indicating that it interplayed
with 60 different circRNAs in this network. In the re-
ranked Top-10 % down-regulated network, 80 miRNAs
with degree value ranging from 28 to 81 were selected
(Additional file 1: Table S3-2). The miRNA hsa-miR-
608 exhibited the highest degree (D = 81), indicating
that it was regulated by 81 different circRNAs in this
network. The distribution of these Top-10 % miRNAs
is depicted in Additional file 3: Figure S2. Using these
Top-10 % miRNAs, up-regulated and down-regulated
miRNA-circRNA networks (designated as Top-10 %
network-mi) were re-enriched on the basis of the fun-
damental miRNA-circRNA connectivity (Additional
file 3: Figure S3). The distribution of degree of the
miRNAs of the re-enriched Top-10 %-mi network is
depicted in Additional file 3: Figure S4.
Then, we re-ranked the Top-10 % network accord-
ing to circRNA-mediated degree (designated as
Top10%-network-ci). In this re-ranked data set, the
degree of up-regulated circRNAs ranged from 1 to
12. The circRNA100550 exhibited the largest degree
(D = 12), indicating that it interplayed with 12 miR-
NAs. The degree of down-regulated miRNAs ranged
from 1 to 15. The circRNA100988 exhibited the lar-
gest degree (D = 15), indicating that it interacted with
15 miRNAs. The distribution of the degree of the cir-
cRNAs of the Top-10 %-ci network is depicted in
Additional file 3: Figure S5. From the figure, we could
observe that a majority of the circRNAs interacted with
only one or two miRNAs (237 circRNAs of D = 1 and
307 circRNAs of D = 2). In order to optimize intracel-
lular validation analyses, we selected a subset of cir-
cRNAs of the largest Degree as the candidates. Here,
we optimized our parameters to select circRNAs with
degree values greater than 9 (Top Degrees, D ≥ 9) and en-
rolled the 12 up-regulated circRNAs and the12 down-
regulated circRNAs with the highest degree values for
intracellular validation studies.
Venn analysis for overlapped circRNA identification by
crosstalk analysis
To determine which circRNAs exhibited overlapping
expression between the C1 and C4 comparison groups,
Venn analyses were performed using the selected 12 up-
regulated and 12 down-regulated circRNAs (The Venn’s
diagram is depicted in Additional file 3: Figure S6). The
details of between-group comparisons are also shown in
Table 1. Four of twelve up-regulated circRNAs were
expressed in both the C1 and C4 groups. Therefore, we
employed qPCR to validate the intracellular expression
of these four circRNAs in their respective T cell subsets
of origin. Unexpectedly, none of the 12 candidate cir-
cRNAs mediated crosstalk in the down-regulated net-
work. To compare the same number of circRNAs/
molecules as in the up-regulated network, we selected
four circRNAs (N = 4, Top-2 Fold Changes in C1 or C4,
respectively) for the intracellular validation in the down-
regulated network.
Table 1 The clinical characteristics of the subjects with CMV seropositivity
Category Elderly group Adult group
Old-old Middle-old Adult-old
Number 6 7 8 8
Age 90.5 ± 2.4 79.6 ± 2.5 69.3 ± 3.1 32.0 ± 4.6
Gender (male vs female) 3vs3 4vs3 4vs4 4vs4
Number of chronic diseasesa 3.4 3.0 2.9 0
Number of daily medications(NNTs)b 5.6 5.3 5.1 0
Numbers of white blood cell(109 L−1) 7.14 ± 3.67 7.09 ± 3.56 7.20 ± 2.98 7.98 ± 3.52
Numbers of PBMC(109 L−1) 0.44 ± 0.25 0.43 ± 0.26 0.44 ± 0.24 0.48 ± 0.21
Numbers of CD8(+)(109 L−1) 0.26 ± 0.14 0.23 ± 0.12 0.25 ± 0.15 0.24 ± 0.11
Percentage ratio of CD28(+)/CD28(-) 43.4 ± 22.1/56.6 ± 33.5 49.1 ± 26.5/57.1 ± 37.8 46.9 ± 22.1/53.1 ± 39.0 55.1 ± 29.2/42.6 ± 29.3
C-reactive Protein(mg L−1) 6.39 ± 2.86 6.26 ± 3.02 6.41 ± 3.27 5.22 ± 1.45
aNumber of chronic disease (multimorbidity) was calculated using 10 age-related/chronic diseases including sustained/primary hypertension, primary hyperlipidemia,
type 2 diabetes, coronary atherosclerotic heart disease, chronic atrial fibrillation, preclinical valvular disease, preclinical chronic obstructive pulmonary disease, subclinical
chronic liver disease, subclinical chronic renal disease, subclinical thyroid disease and long-term(subclinical > 5 years) tumor survivor
bNumber of daily medications were calculated by the number of drugs necessary to treat (NNTs). It was calculatedusing15 categories of pharmaceutical
administration,including:5 oral antihypertensive drugs (angiotensin receptor blockers, angiotensin-converting enzyme inhibitors, calcium channel blockers, beta-receptor
blockers, and hydrochlorothiazide); 4 oral hypoglycemic drugs (sulfonylureas, metformin, glucosidase inhibitors, and thiazolidinediones); insulin or insulin analogues;
2 lipid lowering drugs(statin and fibrate); aspirin; clopidogrel; trimetazidine; CoenzymeQ10; and isosorbidemononitrate sustained-release capsules
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Cellular validation using qPCR
The relative intracellular expression (ratio of intracellular
expression to microarray expression) of the aforemen-
tioned 8 circRNAs is shown in Fig. 1. At the intracellular
level, we found that only circRNA100783 expression sig-
nificantly differed between the C1and C4 groups. This
indicated that the expression of circRNA100783 was
affected by time (C4) and antigen exposure (C1) during
CD28-related CD8(+)T cell ageing. Therefore, we propose
that this circRNA100783 is a potential biomarker in age-
ing T lymphocytes.
circRNA100783-targeted miRNA-mRNA network prediction
and annotation
According to the initial array data analysis, the genomic
locus of circRNA100783 is on chromosome 11and the
Fig. 1 The intracellular validation of candidate circRNAs in C1 and C4. Validation of intracellular circRNA was performed using quantitative polymerase
chain reaction (qPCR; in triplicate) in three randomly selected RNA samples. The level of intracellular expression of the validated circRNA was the average of
these three samples. Prior to determination of the average, the normalized intracellular expression was calculated by the ratio of intracellular expression to
microarray expression. Four up-regulated circRNAs (circRNA100550, circRNA100783, circRNA101328 and circRNA102592) and two down-regulated circRNAs
with Top-2 Degree (circRNA103741 and circRNA101318) were validated in C1, respectively (a). Simultaneously, the same four up-regulated
circRNAs and another two down-regulated circRNAs with Top-2 degree (circRNA104096 and circRNA100264) were validated in C4, respectively
(b). Shown from the figure, only circRNA100783 is significantly differentially-expressed in both C1 and C4. Therefore, we supposed circRNA
1000783 might be a potential biomarker of immunosenescence
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predicted sequence of the best linear transcript isuc001-
mul.1. The molecular interaction of circRNA100783
with its Top-5 miRNA targets is depicted in Additional
file 1: Table S4. Supposing that circRNA100783 is an up-
stream molecular sponge in its circRNA-miRNA-mRNA
network, we predicted a circRNA100783-miRNA-gene
network using Targetscan and miRanda. A total of Top-
18 miRNAs (miRNA-dependent cutoff value -0.11)
andTop-6 miRNAs (mRNA-dependent cutoff value
-0.38) were finally determined in this network (Fig. 2).
Using DAVID function annotation, circRNA100783 was
predicted to be associated most strongly with alternative
splicing, as well as with splice variation and phosphopro-
tein function (Additional file 3: Figure S7). Given the strong
correlation of the biogenesis of circRNAs with splicing and
splice variation, it is possible that circRNA100783 functions
in the regulation of a phosphoprotein that is involved in a
molecular mechanism that leads to the age-related pheno-
typic loss of CD28 from CD8(+) T cells.
In the present study, we employed high-throughput
circRNA microarrays to construct profiles of differen-
tially expressed circRNAs in CD28-associated CD8(+)T
cells in the elderly and adult subjects (C1,C2,C3 and
C4). Then we used a step-wise bioinformatics protocol
to optimize the Top differentially expressed candidate cir-
cRNAs, and then identify those circRNAs having expres-
sion profiles that overlap between the CD28(+)CD8(+)T
cells and CD28(-)CD8(+)T cells from elderly donors (C1),
as well as between the CD28(-)CD8(+)T cells from elderly
and adult controls (C4). To narrow the range of the candi-
dates we employed a step-wise optimizing strategy that
consisted of ranking of RNAs (circRNAs or miRNAs) by
degree values, based on their circRNA-miRNA molecular
connectivity. Finally, the commonly expressed candidate
circRNAs in C1 and C4 were validated in their respective
T cell populations. Among these, the up-regulated cir-
cRNA100783 was the only candidate molecule that
appeared to play both antigen-dependent (C1) and age-
dependent (C4) roles in CD8(+) T cells during ageing.
Therefore, circRNA100783 may serve as a novel bio-
marker of immunosenescence.
Several sources of heterogeneity could hamper ageing
studies and we designed our analysis to minimize this
pitfall. First, “absolute” healthy seniors were rare, while
the common elderly population was affected with numer-
ous chronic diseases (multimorbidity). Moreover, the
increased heterogeneity of clinical phenotypes in the eld-
erly was also correlated to age. To minimize this clinical
heterogeneity, we enrolled representative elderly patients
characterized as having “continuously asymptomatic
manifestation” or “apparent health”, the phenomena of
which are rather prevalent in the general population. Sec-
ond, over a lifetime, individuals may be exposed to several
types of antigens that contribute to T cell immunosenes-
cence. One characteristic phenotype is the eventual loss of
CD28 from the CD8(+) T cell surface (CD28 exhaustion).
Fig. 2 The biomathematical predicted circ000783-targeted circRNA-miRNA-mRNA/gene network. The circ000783-targeted circRNA-miRNA-mRNA/
gene network is predicted based on sequence-pairing prediction. There are 73 miRNAs and 1930 genes being targeted in the present
circ000783–miRNA-mRNA/gene network (miRNA-dependent cutoff value -0.11, mRNA-dependent cutoff value -0.38). Shown in this figure, miR-125a-5p
exhibited the highest degree, followed by miR-33a-5p,miR-33b-5p,miR-580-3p,miR-499a-5p and miR-34b-3p
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Cytomegalovirus (CMV) antigens are believed to elicit the
greatest clonal expansion of CD8(+) T cells in healthy indi-
viduals during ageing [6, 7, 22]. Moreover, infection by
CMV results in changes in gene expression in the aged im-
mune system that are not observed in CMV-negative indi-
viduals [23]. Thus, to diminish the between-antigen
heterogeneity, we limited our studies to subjects who
tested seropositive for CMV according to microarray de-
tection. Third, we examined samples of CD28(+)CD8(+) T
cells and CD28(-)CD8(+) T cells from the same individuals,
as well as among the elderly and controls groups.
A large amount of RNA is required to perform circRNA
microarray analysis. However, even after increasing the
blood sample size to 50 mL, we could not isolate a suffi-
cient amount of RNA from CD28(+)/(-)CD8(+) T cell sub-
sets collected from elderly subjects. We propose that
either the number of CD8(+)T cells or the total RNA from
each cell, or both, decreased during ageing. Typically, cel-
lular circRNAs are in relatively low abundance compared
to their linear counterparts [24] and, therefore, we found
it necessary to pool total RNA from several donors into
one sample. To avoid potential molecular interaction, we
constructed age-related subgroups of old donors, instead
of using a random pooling protocol, to decrease the
between-individual heterogeneity in the elderly group.
Consequently, the elderly group was partitioned into three
age-dependent subgroups: the adult-old subgroup (aged
65-74, n = 8); the middle-old subgroup (aged 75-84, n = 7)
and the old-old subgroup (aged 85-94, n = 6).
Although 7,112 human circRNAs have been identified,
and are estimated to comprise at least 10 % of the tran-
scripts accumulating from their loci, most circRNAs are
expressed in only a few cell types and in low abundance
[25]. Based on the current literature, it is unclear if, and
to what extent, circRNAs regulate target miRNAs through
sequence pairing. The elucidation of the molecular mech-
anism of circRNA-miRNA interactions would require
numerous and extensive binding studies. A previous
report showed that low levels of circRNAs may not be
sufficient to affect the target molecules (Denzler et al.
2014). In view of this, we supposed that most circRNAs
in the integrated circRNA-miRNA network played weak
and transient interactions. Therefore, we designed a step-
wise biomathematical protocol to identify candidates
among differentially-expressed circRNAs based on their
connectivity to target miRNA (independent of fold
change). We considered that circRNAs which exhibited
greater connectivity to miRNAs than did other circRNAs
were more likely to play a role in the CD28 loss from
CD8(+) T cell surfaces during ageing. After a basic
circRNA-miRNA connectivity network was constructed, a
step-by-step biomathematical analysis was performed.
The strategy we developed to analyze the expression
of candidate circRNA consisted of three steps: 1)
ranking theTop-5 miRNA targets in the circRNA-
miRNA network and selecting the Top-10 % miRNAs
according to miRNA-mediated connectivity to construct
the Top-10 %-mi network, 2) re-ranking the Top-10 %-mi
network according to circRNA-mediated connectivity to
obtain a Top-10 %-ci network and, 3) identifying candi-
date circRNAs with a degree value of 9 or greater in the
Top-10 %-ci network. Using the step-wise analysis, twelve
up-regulated circRNAs and down-regulated circRNAs
were identified as candidates for intracellular validation.
We then employed a Venn diagram to explore which of
these circRNA molecules exhibited overlapping ex-
pression in both the C1 and C4 comparison groups
(Additional file 3: Figure S6). This permitted us to
visualize changes in expression due to antigen-accumulated
alterations (C1) and age (4). As shown in Table 1 (upper
panel), a total of twelve up-regulated candidate circRNAs
were distributed in the four comparison groups. Of the six
up-regulated circRNAs from C1 and ten up-regulated
circRNAs from C4, four molecules (circRNA100550,
circRNA100783, circRNA101328 and circRNA102592)
exhibited overlapping expression in the two groups. We
subsequently validated these circRNAs in the corre-
sponding T cell subsets using qPCR. However, none of the
down-regulated circRNAs were expressed in the four
comparison groups (Table 2, lower panel). Therefore, we
selected for validation two circRNAs which ranked in the
Top-2, according to Fold Change, in the two comparison
groups. Among these four up-regulated overlapping cir-
cRNAs, only the differential expression of circRNA101318
was validated by intracellular qPCR detection.
Until now, only two circRNAs have been functionally
verified as miRNA sponges among thousands of detected
circRNAs with predicted miRNA binding sites [16, 17].
However, studies of SNP density at miRNA seed sites in
3' untranslated regions and flanking sequences, as well
as at random sites, suggest that many of the predicted
miRNA binding sites in circRNAs are functional and
under similar selective pressure as are miRNA binding
sites in mRNAs [26]. In the present study, we also pre-
dicted that circRNA100783 may function as a “sponge”
to its targeted miRNAs in the predicted circRNA-
miRNA-mRNA network. Then we used DAVID bio-
informatics resources (Huang da et al., 2009) and KEGG
pathway analysis (Kanehisa et al., 2006) to functionally
annotate the predicted target genes of circRNA100783.
According to our annotation, circRNA100783 is pre-
dicted to be involved in three possible functions includ-
ing alternative splicing, splice variation and association
with phosphoprotein(s) (Additional file 3: Figure S7).
Conclusions
In the present study, we used the cross-comparison of
circRNA microarrays and step-wised bioinformatics to
Wang et al. Immunity & Ageing  (2015) 12:17 Page 6 of 10
determine that circRNA100783 may be involved in the
loss of CD28 in CD8(+)T cells during ageing. A circRNA-
miRNA-gene network suggests that circRNA100783,
might regulate phosphoprotein-related signal transduction
on CD28-dependent CD8(+)T cell ageing. A longitudinal
study may verify circRNA100783 as a potential intracellu-
lar biomarker of immunosenescence.
Methods
Participants
The elderly donors were chosen from a group of partici-
pants in the Longitudinal Project on Witnessing Ageing
(LPWA) in the Geriatrics Department of the First Affili-
ated Hospital of Harbin Medical University [27]. Each
individual’s annual medical documentation, including
chronic disease, long-term clinical complaints, physical
examinations, laboratory measurements, imageological
diagnoses, daily life style, daily necessary medication,
and pharmaceutical adjustments were comprehensively
reviewed. Subjects aged 65 to 94 who were continuously
asymptomatic in the recent twelve months were initially
enrolled as “apparently healthy elderly individuals”. After
testing for latent human cytomegalovirus (CMV) infection
by CMV-IgG, the CMV- seronegative subjects were ex-
cluded from the study. Adult CMV-seropositive healthy
donors aged 25-35, who volunteered in the Geriatric
Department, were enrolled and assessed by medical
examination. All participants agreed to participate in the
study with written content. The study was approved by
the First Affiliated Hospital of HarbinMedical University of
Medicine Ethic Committee and the research was carried
out in compliance with the Helsinki Declaration.
Table 2 The microarray Fold Change of the candidate circRNAs that were step-wise selected
circRNA Degree C1:Q1 vs Q2 C4:Q2 vs Q4 C2:Q3 vs Q4 C3:Q1 vs Q3
Up-regulated circRNAs Fold Change
hsa_circRNA_100550a 12 2.1051912 2.7916539 4.9934264
hsa_circRNA_001259 10 2.9541118 4.9224802
hsa_circRNA_101635 10 2.6649119 2.339966
hsa_circRNA_102592 10 2.1983682 2.1898953
hsa_circRNA_100315 10 3.8537081 2.9419454
hsa_circRNA_101358 9 5.5122991 2.8866116 3.6304114
hsa_circRNA_101384 9 10.8204701 2.7116116 3.3926842
hsa_circRNA_102592a 9 3.8876708 2.7185627 6.3889501
hsa_circRNA_400075 9 6.9227289 5.663918 4.0526795
hsa_circRNA_104981 9 4.8466812
hsa_circRNA_100783a 9 3.1348047 4.1833976 7.213918
hsa_circRNA_101328a 9 2.2217774 2.2872726 2.6027261
Down-regulated circRNAs Fold Change
hsa_circRNA_100988 15 5.6605839 2.086644 2.938461
hsa_circRNA_100989 12 5.4144951 2.6900132
hsa_circRNA_103801 10 2.1387435 3.3525614
hsa_circRNA_104646 10 2.5271826 2.1783708
hsa_circRNA_100807 10 2.4750588 3.7937131
hsa_circRNA_101318c 10 7.3547169 6.3808594 3.0753515
hsa_circRNA_100264b 10 4.3266365 3.2787265
hsa_circRNA_103741c 10 7.7727788 2.5595041 3.8058778
hsa_circRNA_103572 10 3.2713424
hsa_circRNA_104096b 10 3.2940966 2.0907926
hsa_circRNA_104266 9 4.5747819 2.0283626 2.3366408
hsa_circRNA_103623 9 2.1655964 2.2533911
aUp-regulated overlapping circRNAs of C1 and C4 (FC underlined)
bDown-regulated circRNAs with Top-2 FC ofC1
cDown-regulated circRNAs with Top-2 FC of C4
Note: C1:Q1 vs Q2 (CD28(+)CD8(+)T cells vs CD28(-)CD8(+)T cells in the elderly); C2:Q3 vs Q4 (CD28(+)CD8(+)T cells vs CD28(-)CD8(+)T cells in the adult); C3 = Q1
vs Q3 (CD28(+)CD8(+)T cells in the elderly vs the adult); C4 = Q2vsQ4 (CD28(-)CD8(+)T cells in the elderly vs the adult)
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Isolation of CD28(+)CD8(+) T cells and CD28(-)CD8(+)T
cells by flow cytometry sorting
A 20 mL intravenous blood sample was taken from each
participant in the morning. Peripheral blood mononuclear
cells (PBMCs) derived using Ficoll-Hypaque Plus gradient
centrifugation were incubated in fluorescence-activated
cell sorter (FACS) buffer with anti-CD8-phycoerythrin (PE;
BD Biosciences) and anti-CD28-fluorescein isothiocyanate
(FITC; BD Biosciences) for 30 min. Then PBMCs were
washed in FACS buffer, resuspended in 1 % paraformalde-
hyde in FACS buffer, and sorted in a FACSCanto flow cyt-
ometer (BD Biosciences) in the National Key Laboratory of
Harbin Vegetarian Research Institute. CD28(-)CD8(+)T
cells and CD28(+)CD8(+)T cells from each donor were
collected using two sterile collection tubes, respectively,
for RNA extraction and analyses.
circRNA microarray hybridization
Total RNA from either CD28(-)CD8(+)T cells or
CD28(+)CD8(+)T cells from the same subject was
extracted and quantified using the NanoDrop ND-1000.
RNA was prepared and stored at -80 °C for the cellular
validation. RNA from each sample was subjected to
microarray analysis and hybridization according to the
manufacturer’s protocol (Arraystar). An aliquot consist-
ing of 10 % of the RNA from each sample was reserved
for qRNA analysis.
circRNA microarray data analysis
Eight RNA samples extracted from either CD28(+)CD8(+)
T cells or CD28(-)CD8(+) T cells were pooled into one
RNA sample for one microarray detection (i.e. eight micro-
arrays were performed). Then, data from 6 microarrays
using RNA isolated from the elderly group were pooled
into groups Q1 (CD28(+)CD8(+)) or Q2 (CD28(-)CD8(+)),
respectively. Data from-two microarrays using RNA
isolated from the adult cohort were analyzed as Q3
(CD28(+)CD8(+)) or Q4 (CD28(-)CD8(+)), correspond-
ingly. Figure 3 schematically depicts the grouping of the
eight circRNA microarrays and the four cross-group com-
parisons (C1 =Q1 vs Q2; C2 =Q3 vs Q4; C3 =Q1vs Q3;
C4 = Q2 vs Q4) that were performed (see Additional
file 1: Table S2 for the pooling and grouping protocol).
Identification of the circRNA-miRNA connectivity
Using microarray analysis we initially identified the cir-
cRNAs that exhibited a more than 2-fold change in
expression. Then their respective miRNA targets, which
Fig. 3 Schematic strategy of pooling circRNA microarray profiles. Eight microarrays are depicted by 8 green circles. After eight microarray profiles
were individually acquired, three microarray profiles detecting CD28(+)CD8(+)T cells from three age-dependent elderly subgroups were pooled as
Q1,and three microarray profiles detecting CD28(-)CD8(+)T cells from three age-dependent elderly subgroups were pooled as Q2. Consequently,
four cross-group comparisons were performed as: Comparison1 (C1:Q1 vs Q2 indicating CD28(+)CD8(+) vs CD28(-)CD8(+) T cells in the elderly);
Comparison2 (C2: Q3 vs Q4 indicating CD28(+)CD8(+) vs CD28(-)CD8(+)T cells in the adult); Comparison 3 (C3:Q1 vs Q3 indicating CD28(+)CD8(+)T
cells in the elderly vs in the adult); and Comparison4 (C4: Q2 vs Q4 indicating CD28(-)CD8(+)T cells in the elderly vs in the adult)
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were predicted based on sequence-pairing, were identi-
fied by TargetScan and verified by miRanda; thus the
basic circRNA-miRNA connectivity was established. All
subsequent biomathematical analyses were based on this
basic molecular connectivity.
Step-wise biomathematical circRNA candidate
optimization
After the basic circRNA-miRNA connectivity was deter-
mined, we focused our efforts on finding overlapping
circRNA profiles between the C1 and C4 comparison
groups. However, among the Top-10 circRNAs listed in
Additional file 1: Table S1, none were commonly
expressed in C1 and C4. Even when we expanded our
list of candidates to include the Top-50 circRNAs, we
observed no overlapping circRNA expression in C1 and
C4. Therefore, we employed a step-wise biomathemati-
cal analysis to identify potential overlapping circRNAs
(Animated details are depicted in Additional file 4:
Online Supplemental PPT1).
First, to focus the targeted miRNA profile, the miRNA
support vector regression (mirSVR) algorithm was used
to score and rank the efficiency of the predicted micro-
RNA targets (Betel et al. 2010). Accordingly, for each
circRNA exhibiting greater than a 2-fold expression
level, we identified 5miRNAs with the highest mirSVR
(Top-5). Thus a “Top-5-mi” circRNA-miRNA network
was established (one circRNA connecting to five miR-
NAs, miRNA-mediated Degree = 5). Second, this Top-5
circRNA-miRNA network was re-ranked with respect to
circRNA-mediated connectivity (one miRNA connecting
to N circRNAs, circRNA-mediated Degree = N). Then,
circRNAs were ranked according to degree and the Top-
10 % candidates were identified for these restricted pro-
files. The cutoff of 10 % was selected empirically according
to our previous bioinformatics experience. Using these
Top-10 % circRNAs, a “re-enriched” Top-10 % miRNA-
circRNA network was established (“Top-10 %-mi”). Third,
this Top-10 % network was re-ranked according to the
miRNA-mediated degree (one circRNA connecting M
miRNAs,Degree =M). Our final investigation focused on
circRNAs that exhibited degrees of 9 or greater in this re-
ranked Top-10 % network (“Top-10 %-ci”). The
selectedTop-9 circRNAs were subjected to Venny analysis
to discern overlapping candidates (Table 1).
Validation of candidate circRNAs using qRT-PCR
Validation of circRNA was performed using quantitative
polymerase chain reaction (qPCR; in triplicate) in three
randomly selected RNA samples. Divergent primers
(instead of commonly used convergent primers) were
designed and optimized for eight circRNAs. The se-
quence of circRNA results were acquired from the
database “circBase”. The Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) housekeeping gene was used
as a control (Details are shown in Additional file 1:
Table S5). To ensure the accuracy of the results, we
verified the target specificity of the PCR primers using
BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi). The ap-
pearance of a single-peak in the melting curve indicated
the specificity of the PCR results. The data were analyzed
using the ΔCt method. Validation was designated by the
ratio of the differential cellular expression/differential
microarray expression.
Annotation and function prediction for the validated
circRNAs
Validated candidate circRNAs were used as seeds to enrich
a circRNA-miRNA-gene network according to the cutoff
value determined using mirSVR. The predicted gene func-
tions in the networks were annotated using Gene Ontology
(GO) and KEGG Pathway using Database for Annotation,
Visualization and Integrated Discovery (DAVID) [28].
Statistical analysis
Quantile normalization and subsequent data processing
were performed using the R software package. All other
statistical data were analyzed and visualized by GraphPad
Prism5.0 (GraphPad Software, La Jolla, CA). The signifi-
cance of qPCR validation of C1 and C4 were tested by
Student’s t test (P < 0.05)and was considered statistically
significant.
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